Results 181 to 190 of about 45,441 (213)
Some of the next articles are maybe not open access.
Leukemia & Lymphoma, 2013
Over the past decade, it has become increasingly clear that mantle cell lymphoma (MCL) is a more heterogeneous disease than originally recognized. Several groups have reported on a subgroup of patients with a less aggressive course than expected resulting in the term "indolent MCL".
Eric D, Hsi, Peter, Martin
openaire +2 more sources
Over the past decade, it has become increasingly clear that mantle cell lymphoma (MCL) is a more heterogeneous disease than originally recognized. Several groups have reported on a subgroup of patients with a less aggressive course than expected resulting in the term "indolent MCL".
Eric D, Hsi, Peter, Martin
openaire +2 more sources
Mantle cell lymphoma diagnosis
Annales de biologie clinique, 2013Recent classifications of non-Hodgkin's lymphomas based on combination of morphologic, immunophenotypic, and cytogenetic criteria have individualized mantle cell lymphoma (MCL). This clinico-biological entity which accounts for 3 to 10% of all non-Hodgkin's lymphomas, now appears to be a biological and therapeutic model for the understanding and ...
Mohammed, Choukri +7 more
openaire +2 more sources
Oncology Times, 2015
Mantle cell lymphoma (MCL) is a well-defined lymphoid malignant disease characterized by a proliferation of mature B lymphocytes expressing CD5. This rare lymphoma regroups in fact a spectrum of morphological, phenotypic, and clinical pathologies with at least three diseases: the classical nodal MCL, the most common entity, the indolent leukemic ...
Sylvain Carras, Laure Philippe
+4 more sources
Mantle cell lymphoma (MCL) is a well-defined lymphoid malignant disease characterized by a proliferation of mature B lymphocytes expressing CD5. This rare lymphoma regroups in fact a spectrum of morphological, phenotypic, and clinical pathologies with at least three diseases: the classical nodal MCL, the most common entity, the indolent leukemic ...
Sylvain Carras, Laure Philippe
+4 more sources
Arkhiv patologii, 2002
Two morphological variants of mantle cell lymphoma are described: classic and blastoid. The former consists of small and medium-size cells, the latter is represented by cells with lympho- and centroblast morphology. An immunohistochemical examination has established a high degree of cyclic D1 expression by these lymphomas.
Z V, Takhaev +3 more
openaire +1 more source
Two morphological variants of mantle cell lymphoma are described: classic and blastoid. The former consists of small and medium-size cells, the latter is represented by cells with lympho- and centroblast morphology. An immunohistochemical examination has established a high degree of cyclic D1 expression by these lymphomas.
Z V, Takhaev +3 more
openaire +1 more source
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
New England Journal of Medicine, 2020Michael Wang +2 more
exaly
The rapidly changing landscape in mature T‐cell lymphoma (MTCL) biology and management
Ca-A Cancer Journal for Clinicians, 2020Enrica Marchi
exaly